ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Internal Medicine

Top Internal Medicine Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
HARIN CHHATIAWALA M.D.

Internal Medicine

12,316

$734K

536
414 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $61

JOSEPH ARULANDU MD

Internal Medicine

12,232

$787K

606
450 are 65+

2%
patients receiving schedule two controlled substances

Avg: 6%

25%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $61

JAMES GOSZKOWSKI M.D.

Internal Medicine

12,207

$662K

393
339 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $61

MAHENDRA KALRA M.D.

Internal Medicine

12,180

$595K

643
556 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $61

OKECHI NWABARA MD

Internal Medicine

12,170

$707K

567
376 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $61

LAWRENCE JUDY MD

Internal Medicine

12,156

$549K

566
508 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $61

ABDELMESSIAH GUIRGUIS MD

Internal Medicine

12,090

$660K

337
189 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

26%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $61

MARK DELBELLO M.D.

Internal Medicine

12,082

$857K

497
438 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$71
Average prescription price

Avg: $61

DOUGLAS FRANKE MD

Internal Medicine

11,998

$716K

710
665 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $61

STEVEN SAMUELS MD

Internal Medicine

11,977

$813K

550
445 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

29%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $61

ROBERT RUSCHE MD

Internal Medicine

11,950

$658K

419
378 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 16%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $61

RAVINDER SURAKANTI M.D.

Internal Medicine

11,933

$572K

385
301 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

21%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $61

JOSEPH HESTER MD

Internal Medicine

11,860

$685K

521
413 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $61

CHARLES ROSE MD

Internal Medicine

11,845

$711K

397
344 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $61

RICHARD FOSTER M.D.

Internal Medicine

11,802

$718K

358
286 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

27%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $61

YOGESHCHANDRA AMIN M.D.

Internal Medicine

11,776

$1.06M

376
283 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$90
Average prescription price

Avg: $61

WILLIAM SCHMALZ MD

Internal Medicine

11,756

$1.35M

475
404 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 25%

$115
Average prescription price

Avg: $61

SHREYAS DESAI M.D.

Internal Medicine

11,647

$697K

634
379 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $61

MEDHAT GIRGIS MD

Internal Medicine

11,584

$587K

377
312 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

21%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $61

CHARLES HEDDE M.D.

Internal Medicine

11,569

$433K

355
327 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$37
Average prescription price

Avg: $61

ROBERT STEVENSON M.D.

Internal Medicine

11,559

$706K

523
394 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $61

JOHN DESANTO

Internal Medicine

11,551

$682K

537
448 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $61

YOUSSEF SIAGE M.D.

Internal Medicine

11,528

$590K

500
440 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $61

PATRICE YATES MD

Internal Medicine

11,478

$589K

518
452 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

25%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $61

JOSE AGUSTI M.D.

Internal Medicine

11,450

$618K

493
377 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

21%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank